\
&
Contact us
\
&
Contact us
This was 4 years ago
LocationOnline
ProgrammesThe Belgian COST Contact Points will organize a COST Info Session for Proposers in order to support researchers/actors that are preparing a COST proposal as the main proposer for the next COST Open Call OC-2021-1 which will close on 29 October 2021 at 12:00 noon CET.
This info session is planned for Tuesday 4 May 2021 from 10h00-12h00 and will take place virtually. Priority will be given to main proposers but secondary proposers and research administration staff are also welcome to attend this info session. Participation is only official and guaranteed after receiving a written confirmation!
More information on the agenda and registration is available here.
Registration remains open until 27 April 2021.
N.B.: Researchers/actors that are looking for general COST information are advised to watch the recording of the COST Online Info Day which took place on 23 February 2021.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
